Ameritas Investment Partners’s Cidara Therapeutics CDTX Stock Holding History

Ameritas Investment Partners’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,591	Closed	-$351K	–	3121
2025 Q4	$351K	Buy	1,591 +299	+23%	+$48.3K	0.01%	951
2025 Q3	$124K	Sell	1,292 -409	-24%	-$26.1K	﹤0.01%	1554
2025 Q2	$82.9K	Buy	+1,701	New	+$40.9K	﹤0.01%	1878
2021 Q2	–	Sell	-148	Closed	-$8K	–	3083
2021 Q1	$8K	Hold	148	–	–	﹤0.01%	2916
2020 Q4	$6K	Hold	148	–	–	﹤0.01%	2932
2020 Q3	$8K	Hold	148	–	–	﹤0.01%	2795
2020 Q2	$11K	Buy	+148	New	+$9.59K	﹤0.01%	2662
2017 Q2	–	Sell	-54	Closed	-$8K	–	3004
2017 Q1	$8K	Buy	+54	New	+$9.48K	﹤0.01%	2754

Ameritas Investment Partners's CDTX Position: Q1 2026 in Review

Ameritas Investment Partners sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 1,591 shares — an estimated $351K sold.

Ameritas Investment Partners first reported a position in CDTX in Q1 2017 and held it in 8 quarters. The position peaked at $351K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Ameritas Investment Partners reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Ameritas Investment Partners sold 1,591 Cidara Therapeutics shares in Q1 2026, an estimated $351K.
Ameritas Investment Partners first reported a position in Cidara Therapeutics in Q1 2017 and held it in 8 quarters.
Ameritas Investment Partners's Cidara Therapeutics position peaked at $351K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.